A New Pill For Eczema

Author: Dr. Nadia Satya Urato, MD, FAAD

A new pill for eczema is in final trials and showing great promise! Abrocitinib is a JAK inhibitor that is in phase three trials and seems to be effective and with a reasonable safety profile. Stay tuned!

POSITIVE TOP-LINE RESULTS FROM PFIZER’S PHASE 3 JADE DARE TRIAL COMPARING THE EFFICACY OF ABROCITINIB AND DUPILUMAB FOR MODERATE TO SEVERE ATOPIC DERMATITIS

Category: Eczema / dermatitis Tags: eczema, abrocitinib, JAK inhibitor

Our Location

3231 Gulf Gate Dr. Suite 105, Sarasota, FL, 34231

Hours of Operation

Our Regular Schedule

Monday:

8:00 am-5:00 pm

Tuesday:

8:00 am-5:00 pm

Wednesday:

8:00 am-5:00 pm

Thursday:

8:00 am-5:00 pm

Friday:

8:00 am-5:00 pm

Saturday:

Closed

Sunday:

Closed